Lung Cancer Equipment
-
Manufactured by CTIBiotechbased in FRANCE
Although much is known about the appearance, growth and spread of cancer in the human body, effective and rapid treatments for many cancer types are yet to be found. Chemo- and radio- therapies have made much progress in the last 20 years, but many such therapies are non-specific, leaving the patient to deal with severe side ...
-
Manufactured by Veracyte, Inc.based in USA
Avoiding unnecessary procedures, speeding time to diagnosis and appropriate treatment. Lung cancer is the leading cancer killer worldwide, causing approximately 1.8 million deaths each year. Veracyte’s comprehensive portfolio of lung cancer genomic tests is designed to improve outcomes for patients at each ...
-
Manufactured by Mesothelioma + Asbestos Awareness Centerbased in USA
Lung cancer is one of the most common cancers, and researchers estimate about 3 – 4% of all cases can be attributed to asbestos ...
-
Manufactured by Menssana Research Inc.based in USA
Every year in the U.S.A., 99,000 men and 78,000 women develop lung cancer, and only 14% of them are still alive five years later. Fortunately, early detection and treatment can reduce the number of deaths. Clinical studies at Menssana Research, Inc. have shown that breath biomarkers accurately identify lung cancer, and this has ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
-
Manufactured by Amoy Diagnostics Co., Ltd.based in CHINA
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in NSCLC for EGFR, HER2, KRAS and BRAF genes are respectively 10-50%, 1-4%, 5-25% and 1-2%. About 3-7%, ...
-
Manufactured by Nucleix Ltd.based in USA
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. Annual imaging (low-dose CT scans) is ...
-
Manufactured by 20/20 GeneSystems Inc.based in USA
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA Lic# 21D2037411). PAULA’s Test is meant for use in patients at high risk of lung ...
-
Manufactured by Eutilex Co.,Ltd.based in SOUTH KOREA
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove ...
-
Manufactured by Lineage Cell Therapeutics, Inc.based in USA
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our pluripotent cell technology using a directed differentiation method, is comprised of a ...
-
Manufactured by Intellogic LLCbased in RUSSIA
. Meanwhile chest CT scan makes it possible to detect a significantly larger number of diseases, especiallylung ...
-
Manufactured by Ocean Biomedicalbased in USA
, the tumor suppressor PTEN, and p53. In addition, OCX-253 is a master stimulator of immune checkpoint inhibitor pathways. and plays a critical role in the pathogenesis of primary and metastatic lung cancer. Other disorders for which it shows promise include glioblastoma multiforme and metabolic ...
-
Manufactured by T-Cure BioScience, Inc.based in USA
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. T-Cure estimates that KK-LC-1 is expressed in 80% gastric cancer, 75% triple negative breast cancer (TNBC), 45% non-small cell ...
-
Manufactured by Amadixbased in SPAIN
It can also be used as a tool for a high-risk screening population in combination with Low Dose Computed Tomography (LDCT). DiagnoLung identifies and measures proteins which are differentially expressed in blood samples of individuals with Lung ...
-
Manufactured by Vitro Biopharmabased in USA
Human Lung Adenocarcinoma Cancer Associated Fibroblasts; Cryopreserved at a low passage; Stage: III; High passage capabilities; Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability); Able to grow in low oxygen (1% - 5% ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used alone or in combination to treat ovarian cancer or breast cancer or lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used as first-line therapy for ovarian cancer or breast cancer or lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat pleural mesothelioma and non-small-cell lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat breast cancer, non-small-cell lung cancer, prostate cancer, ovarian cancer, head and neck cancer, and esophageal ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you